Studies on several malignancies (including renal cancer) suggest that the IL33/IL33Rα axis could be important in tumorigenesis through exerting direct effects on malignant cells [64] or indirectly through effects on stromal cells [65], including altering the regulation of tumor angiogenesis [66]. The gene discussed is IL33; the disease is renal carcinoma.